92490-75-0Relevant academic research and scientific papers
NITROGEN-CONTAINING HETEROCYCLIC COMPOUND
-
Paragraph 0333, (2017/08/01)
The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity and useful as a medicament such as a prophylactic or therapeutic drug for Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies and the like, and the like. The present invention relates to a compound represented by the formula (I) or a salt thereof. wherein each symbol is as described in the attached DESCRIPTION.
Photoisomerization of 4-Hydroxypyrylium Cations in Concentrated Sulfuric Acid
Pavlik, James W.,Patten, Arthur D.,Bolin, David R.,Bradford, Kenneth C.,Clennan, Edward L.
, p. 4523 - 4531 (2007/10/02)
Irradiation of di-, tri-, and tetraalkyl-4-hydroxypyrylium cations in concentrated sulfuric acid leads to the formation of 2-hydroxypyrylium cations as phototransposition products and, in certain cases, to furyl cations by a photo-ring-contraction reaction.Product analysis by spectroscopic techniques, deuterium labeling, and unambiguous synthesis reveals that 2-hydroxypyrylium cations are formed by two distinct transposition patterns and accordingly, by two distinct mechanistic pathways.The bond-forming and -breaking requirements of the major transposition pattern, which constitutes approximately 95percent of the reaction, are consistent with a mechanism initiated by 2,6-bridging in the first excited state of the 4-hydroxypyrylium cation.Similarly, the bond-formation and -breaking requirements of the minor pattern are consistent with a mechanism involving 2,5-bridging in the first excited state of the starting cation.
